Poorly functioning blood vessels lead to muscle wasting in cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Nov-2025 03:11 ET (13-Nov-2025 08:11 GMT/UTC)
A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results were published on Wednesday, May 28, in The New England Journal of Medicine and could have “transformative implications” for patients, according to an editorial that accompanied the study written by Bradley Maron, MD, Professor of Medicine and Director of the Hypertension Program at the University of Maryland School of Medicine.
Salk Institute scientists analyzed almost 200 cannabis genomes to create the most comprehensive, high-quality, detailed genetic atlas of the plant to date. The atlas reveals unprecedented diversity and complexity within the species, sets the stage for advances in cannabis-based agriculture, medicine, and industry, and builds on a 10,000-year long relationship between humans and cannabis, showing that cannabis can be as important as other crops like corn or wheat.
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.
Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) and is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.